From the Editor

From the Editor

Quo vadis, psychopharmacology?

Innovation in psychopharmacology depends on overcoming multiple challenges that stifle drug discovery and development

From the Editor

Shattering dogmas

The best way to rid our specialty of unproven tenets is to seek scientific basis for everything we do

Pages